banner2

Getting started
Onglyza Hydrate CAS 945667-22-1

Onglyza Hydrate CAS 945667-22-1 - Manufacturers, Suppliers, Factory from China

Onglyza Hydrate CAS 945667-22-1, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

CAS 945667-22-1 Purity 99.0 (HPLC) API Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — CAS 945667-22-1 Purity >99.0% (HPLC) API
Read More

CAS 945667-22-1 Purity >99.0% (HPLC) API

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

D-(+)-Raffinose Pentahydrate CAS 17629-30-0 Assay >99.0% (HPLC) Factory

D-(+)-Trehalose Dihydrate CAS 6138-23-4 Assay >99.0% (HPLC) Factory

(-)-2,3:4,6-Di-O-Isopropylidene-2-Keto-L-Gulonic Acid Monohydrate CAS 68539-16-2 Assay (UV) 98.0~102.0%

Nickel(II) Chloride Hexahydrate CAS 7791-20-0 Ni ≥22.0% Factory

banner4

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.06.01 01:48:50
2022.05.30 18:24:06
2022.05.19 15:38:20
2022.03.16 15:11:54
2021.12.13 10:20:01
2021.11.04 09:23:57

related search